Medicover AB (publ)
MCVEF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $697 | $597 | $578 | $556 |
| % Growth | 16.8% | 3.2% | 4% | – |
| Cost of Goods Sold | $533 | $455 | $445 | $435 |
| Gross Profit | $163 | $142 | $133 | $121 |
| % Margin | 23.5% | 23.8% | 23% | 21.7% |
| R&D Expenses | $0 | $0 | $0 | $7 |
| G&A Expenses | $0 | $73 | $70 | $71 |
| SG&A Expenses | $113 | $100 | $97 | $97 |
| Sales & Mktg Exp. | $0 | $27 | $27 | $27 |
| Other Operating Expenses | $0 | $0 | $0 | -$7 |
| Operating Expenses | $113 | $100 | $97 | $97 |
| Operating Income | $51 | $42 | $36 | $23 |
| % Margin | 7.3% | 7% | 6.2% | 4.2% |
| Other Income/Exp. Net | -$20 | -$17 | -$10 | -$13 |
| Pre-Tax Income | $30 | $25 | $26 | $10 |
| Tax Expense | $8 | $7 | $7 | $3 |
| Net Income | $23 | $19 | $20 | $9 |
| % Margin | 3.3% | 3.2% | 3.5% | 1.5% |
| EPS | 0.15 | 0.13 | 0.13 | 0.057 |
| % Growth | 15.4% | 0% | 126.9% | – |
| EPS Diluted | 0.15 | 0.13 | 0.13 | 0.057 |
| Weighted Avg Shares Out | 151 | 151 | 150 | 150 |
| Weighted Avg Shares Out Dil | 151 | 151 | 151 | 150 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $1 |
| Interest Expense | $19 | $17 | $15 | $16 |
| Depreciation & Amortization | $65 | $55 | $51 | $50 |
| EBITDA | $115 | $96 | $92 | $75 |
| % Margin | 16.5% | 16.1% | 15.9% | 13.6% |